Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

TRIPLE POINT VCT 2011 PLC Regulatory Filings 2023

Jul 18, 2023

4890_prs_2023-07-18_25b88e5f-362a-45d7-b3b3-dd46ff493855.html

Regulatory Filings

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 3732G

Triple Point VCT 2011 PLC

18 July 2023

18 July 2023

Triple Point VCT 2011 plc

(the "Company")

OFFER UPDATE

The Board of Triple Point VCT 2011 plc announces that the expected timetable for the final allotment in respect of the 2023/24 tax year (the "Final Allotment") under the Offer, and the closure of the Offer, is as follows:

Deadline for receipt of applications, and cleared funds*, for the Final Allotment 12 noon on 28 July 2023
Final Allotment 28 July 2023
Closing date of the Offer 28 July 2023

*Cheques must be received no later than 12pm on 25 July 2023.

A copy of the prospectus dated 21 September 2022 relating to the Offer has been submitted to the National Storage Mechanism located at https://data.fca.org.uk/#/nsm/nationalstoragemechanism and may be viewed on the Company's website: https://www.triplepoint.co.uk/current-vcts/triple-point-vct-2011-plc/s2539/.

FOR FURTHER INFORMATION ON THE COMPANY, PLEASE CONTACT:

Triple Point Investment Management LLP

(Investment Manager)
Tel: 020 7201 8989
Ian McLennan

Belinda Thomas

The Company's LEI is 213800AOOAQA5XQDEA89

Further information on the Company can be found on its website https://www.triplepoint.co.uk/current-vcts/triple-point-vct-2011-plc/s2539/.

NOTES:

The Company is a Venture Capital Trust incorporated in July 2010 and was established to fund small and medium sized enterprises. The Investment Manager is Triple Point Investment Management LLP.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCNKFBDFBKKAOD